Release notice of a new model of cell imaging system for drug discovery and regenerative medicine re
SCREEN Holdings Co., Ltd. has developed Cell3iMager duos 2, the latest model of the cell morphology imaging system, which combines the...
About COVID-19 pandemic-2
Dear Customer, We had been teleworking from April 6th due to the spread of COVID-19 infection, but ended today (May 27th) and restart our...
About COVID-19 pandemic
Dear Customer, We will switch to teleworking for the time from April 6 to take action to COVID-19 pandemic. If you have any inquiries...
SCREEN Supplies Additional Funding to Venture Company Developing Cell/Microorganism Research Devices
Kyoto, Japan – August 8, 2019 – SCREEN Holdings Co., Ltd. has decided to provide additional investment capital to AFI Corporation...
SCREEN Develops Cell Image Analysis Software That Utilizes Deep Learning Enables Non-invasive Quanti
Kyoto, Japan - November 19, 2018 - SCREEN Holdings Co., Ltd. has finalized development of new cell image analysis software that uses deep...
SCREEN Joins One-Stop Bioresource Project in Kyoto University
Kyoto, Japan - March 20, 2018 - SCREEN Holdings Co., Ltd. has decided to participate in the one-stop bioresource project in Kyoto...
SCREEN Signs North American Sales Partner Agreement with SciPro
Kyoto, Japan - December 1, 2017 - SCREEN Holdings Co., Ltd. has concluded a sales partnership agreement with SciPro Inc. (headquarters:...
SCREEN Signs European Sales Partner Agreement with LOT
Kyoto, Japan - November 9, 2017 - SCREEN Holdings Co., Ltd. has concluded a sales partnership agreement with LOT-QuantumDesign GmbH...
SCREEN Concludes Capital and Business Tie-up with Venture Company Developing Cell/Microorganism Eval
Kyoto, Japan - September 11, 2017 - SCREEN Holdings Co., Ltd. has finalized a decision to provide investment capital to AFI Corporation...